Purple Biotech Statistics
Total Valuation
Purple Biotech has a market cap or net worth of $5.08 million. The enterprise value is -$898,074.
Important Dates
The last earnings date was Friday, November 15, 2024, before market open.
Earnings Date | Nov 15, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
Current Share Class | n/a |
Shares Outstanding | n/a |
Shares Change (YoY) | n/a |
Shares Change (QoQ) | n/a |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | 319.69M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | n/a |
P/TBV Ratio | 3.24 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.27, with a Debt / Equity ratio of 0.01.
Current Ratio | 1.27 |
Quick Ratio | 1.15 |
Debt / Equity | 0.01 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -48.80 |
Financial Efficiency
Return on equity (ROE) is -34.39% and return on invested capital (ROIC) is -29.18%.
Return on Equity (ROE) | -34.39% |
Return on Assets (ROA) | -24.97% |
Return on Capital (ROIC) | -29.18% |
Revenue Per Employee | n/a |
Profits Per Employee | -$582,900 |
Employee Count | 20 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Dividends & Yields
Purple Biotech does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | n/a |
Shareholder Yield | n/a |
Earnings Yield | -229.29% |
FCF Yield | -340.94% |
Analyst Forecast
The average price target for Purple Biotech is $126.50, which is 5,021.46% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $126.50 |
Price Target Difference | 5,021.46% |
Analyst Consensus | Strong Buy |
Analyst Count | 2 |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Stock Splits
The last stock split was on September 17, 2024. It was a reverse split with a ratio of 0.05:1.
Last Split Date | Sep 17, 2024 |
Split Type | Reverse |
Split Ratio | 0.05:1 |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | n/a |